The Global Congress on Sickle Cell Disease has renewed its commitment to intensify the fight against sickle cell disease (SCD) in Nigeria.
Professor Obiageli Nnodu, Chairperson of the Local Organising Committee, revealed this during a media chat.
“Nigeria plays a crucial role in the global response to sickle cell disease due to its high prevalence,” she said.
The World Health Organisation (WHO) estimates that 7.7 million people live with SCD globally. Out of that number, Nigeria accounts for four to six million cases, with millions more carrying the trait.
Congress to Spotlight African Burden, Inspire Global Solutions
Nnodu announced that Abuja will host the Global Congress on Sickle Cell Disease from June 3 to June 6.
She said the event aims to boost collaboration, inspire innovation, and share proven solutions to manage and eventually eradicate SCD.
“This congress will shine a spotlight on Africa’s burden, especially Nigeria’s, which is the highest globally,” she added.
She recalled that the event first came to Africa in 2010, when Ghana hosted it.
“We are thrilled to welcome the world again. We expect over 500 participants, including many from Nigeria.”
Nnodu also revealed that profiles of top global speakers will be posted daily on their social media platforms.
Strong Partnerships Driving the Mission
She confirmed strong partnerships with the Nigerian Ministry of Health and the Global Sickle Cell Disease Network.
Other partners include Novo Nordisk, Novartis, Revvity, Pfizer, Pierre Fabre Foundation, American Society of Hematology, Bond Chemical Industry Ltd, and the Centre for Communication and Social Impact.
“These partnerships will help us unite researchers, healthcare workers, patients, caregivers, advocates, and policymakers from around the world,” she said.
Nnodu said the congress will present the latest research, treatments, and breakthroughs to improve lives affected by SCD.
The Global Congress on Sickle Cell Disease serves as a leading platform to advance understanding, treatment
